Description
Trabodenoson(INNO-8875, PJ 875) is a potent and highly selective agonist of adenosine A1 receptor agonist. Trabodenoson reduce IOP significantly in glaucoma and OHT patient and OHT patients and was well-tolerated. Trabodenoson is the first of a new class of compounds designed to lower IOP with a mechanism of action that augments the natural function of the trabecular meshwork, the main passageway to transport aqueous tumor out of the eye